LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Topical tofacitinib for the treatment of alopecia areata affecting facial hair

Photo from wikipedia

Alopecia areata (AA) is a common autoimmune condition which can affect any hair-bearing site. Recent studies have demonstrated the effectiveness of Janus kinase inhibitors (JAKis) in the treatment of AA.… Click to show full abstract

Alopecia areata (AA) is a common autoimmune condition which can affect any hair-bearing site. Recent studies have demonstrated the effectiveness of Janus kinase inhibitors (JAKis) in the treatment of AA. Most studies documenting response of AA affecting facial hair to JAKi therapy involve oral administration due to extensive concomitant scalp involvement. However, oral JAKis are associated with adverse effects, e.g. infections, in 2-6% of patients. Topical JAKis may offer a safer alternative for limited disease, or in cases where systemic therapy is contraindicated or not desired.

Keywords: affecting facial; alopecia areata; hair; facial hair

Journal Title: British Journal of Dermatology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.